Skip to main content

Advertisement

Articles

Page 5 of 44

  1. Content type: Research

    Glioblastoma (GBM) is a fatal brain tumor, lacking effective treatment. Epidermal growth factor receptor (EGFR) is recognized as an attractive target for GBM treatment. However, GBMs have very poor responses t...

    Authors: Xuejiao Liu, Xiangyu Chen, Lin Shi, Qianqian Shan, Qiyu Cao, Chenglong Yue, Huan Li, Shengsheng Li, Jie Wang, Shangfeng Gao, Mingshan Niu and Rutong Yu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:219

    Published on:

  2. Content type: Review

    Reprogramming of cancer metabolism is a newly recognized hallmark of malignancy. The aberrant glucose metabolism is associated with dramatically increased bioenergetics, biosynthetic, and redox demands, which ...

    Authors: Jinguan Lin, Longzheng Xia, Jiaxin Liang, Yaqian Han, Heran Wang, Linda Oyang, Shiming Tan, Yutong Tian, Shan Rao, Xiaoyan Chen, Yanyan Tang, Min Su, Xia Luo, Ying Wang, Hui Wang, Yujuan Zhou…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:218

    Published on:

  3. Content type: Research

    Upregulation of RNA polymerase (Pol) III products, including tRNAs and 5S rRNA, in tumor cells leads to enhanced protein synthesis and tumor formation, making it a potential target for cancer treatment. In thi...

    Authors: Xia Liang, Renxiang Xie, Jinfeng Su, Bingqi Ye, Saisai Wei, Zhibing Liang, Rongpan Bai, Zhanghui Chen, Zhongxiang Li and Xiangwei Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:217

    Published on:

  4. Content type: Research

    Chronic myeloid leukemia (CML) is a myeloproliferative disease caused by the constitutive tyrosine kinase (TK) activity of the BCR-ABL1 fusion protein. Accordingly, TK inhibitors have drastically changed the d...

    Authors: M. Mancini, S. De Santis, C. Monaldi, L. Bavaro, M. Martelli, F. Castagnetti, G. Gugliotta, G. Rosti, M. A. Santucci, G. Martinelli, M. Cavo and S. Soverini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:216

    Published on:

  5. Content type: Retraction Note

    The Editor-in-Chief has retracted this article [1] due to concerns about the figures. In Figure 3C, the images from the colony formation assays of all cell lines, excluding the control for the HCCLM9 cell line...

    Authors: Yitao Wang, Xian Qin, Tao Guo, Pengpeng Liu, Ping Wu and Zhisu Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:215

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2017 36:97

  6. Content type: Research

    Gastric cancer is one of the deadliest malignant tumours, with a high incidence in China, and is regulated by aberrantly overexpressed oncogenes. However, existing therapies are insufficient to meet patients’ ...

    Authors: Xiao-Xin Zhang, Bo Ni, Qing Li, Li-Peng Hu, Shu-Heng Jiang, Rong-Kun Li, Guang-Ang Tian, Li-Li Zhu, Jun Li, Xue-Li Zhang, Yan-Li Zhang, Xiao-Mei Yang, Qin Yang, Ya-Hui Wang, Chun-Chao Zhu and Zhi-Gang Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:214

    Published on:

  7. Content type: Research

    High expression of secreted matricellular protein cysteine-rich 61 (CYR61) correlates with poor prognosis in colorectal cancer (CRC). Aberrant enhancer activation has been shown to correlate with expression of ke...

    Authors: Lingzhu Xie, Xuhong Song, Hao Lin, Zikai Chen, Qidong Li, Tangfei Guo, Tian Xu, Ting Su, Man Xu, Xiaolan Chang, Long-Kun Wang, Bin Liang and Dongyang Huang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:213

    Published on:

  8. Content type: Research

    Mucosal melanoma with poor prognosis is a common histopathologic subtype of melanoma among Chinese and other Asian peoples. Regulated microRNAs (miRNAs) have been reported as oncogenes or tumour suppressors in...

    Authors: Huan Tang, Meng Ma, Jie Dai, Chuanliang Cui, Lu Si, Xinan Sheng, Zhihong Chi, Longwen Xu, Sifan Yu, Tianxiao Xu, Junya Yan, Huan Yu, Lu Yang, Yan Kong and Jun Guo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:212

    Published on:

  9. Content type: Research

    Epidermal growth factor receptor (EGFR) and epidermal growth factor receptor pathway substrate 8 (Eps8) have been widely reported to be expressed in various tumors. Eps8 is an important active kinase substrate...

    Authors: Meifang Li, Jilong Yang, Lenghe Zhang, Sanfang Tu, Xuan Zhou, Ze Tan, Weijun Zhou, Yanjie He and Yuhua Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:211

    Published on:

  10. Content type: Research

    Metformin, a biguanide, is one of the most commonly prescribed treatments for type 2 diabetes and has recently been recommended as a potential drug candidate for advanced cancer therapy. Although Metformin has...

    Authors: Shaymaa IK. Al-Juboori, Jayakumar Vadakekolathu, Sarra Idri, Sarah Wagner, Dimitrios Zafeiris, Joshua RD. Pearson, Rukaia Almshayakhchi, Michele Caraglia, Vincenzo Desiderio, Amanda K. Miles, David J. Boocock, Graham R. Ball and Tarik Regad

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:210

    Published on:

  11. Content type: Review

    Growing preclinical evidence shows that short-term fasting (STF) protects from toxicity while enhancing the efficacy of a variety of chemotherapeutic agents in the treatment of various tumour types. STF reinfo...

    Authors: Stefanie de Groot, Hanno Pijl, Jacobus J. M. van der Hoeven and Judith R. Kroep

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:209

    Published on:

  12. Content type: Research

    Thyroid carcinoma includes several variants characterized by different biological and clinical features: from indolent microcarcinoma to undifferentiated and aggressive anaplastic carcinoma. Inflammation plays...

    Authors: Mara Mazzoni, Giuseppe Mauro, Marco Erreni, Paola Romeo, Emanuela Minna, Maria Grazia Vizioli, Cristina Belgiovine, Maria Grazia Rizzetti, Sonia Pagliardini, Roberta Avigni, Maria Chiara Anania, Paola Allavena, Maria Grazia Borrello and Angela Greco

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:208

    Published on:

  13. Content type: Research

    Cisplatin is one of the most widely used chemotherapeutic agents, but its efficacy is limited by its side effects. Hence, it is of great significance to develop novel agents to synergize with cisplatin and dec...

    Authors: Wei He, Yiqun Xia, Peihai Cao, Lin Hong, Tingting Zhang, Xin Shen, Peisen Zheng, Huanpei Shen, Guang Liang and Peng Zou

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:207

    Published on:

  14. Content type: Research

    The aberrant expression of myotubularin-related protein 2 (MTMR2) has been found in some cancers, but little is known about the roles and clinical relevance. The present study aimed to investigate the roles an...

    Authors: Lei Jiang, Jun-yan Liu, Yan Shi, Bo Tang, Tao He, Jia-jia Liu, Jun-yan Fan, Bin Wu, Xian-hui Xu, Yong-liang Zhao, Feng Qian, You-hong Cui and Pei-wu Yu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:206

    Published on:

  15. Content type: Research

    The aim of this study is to explore the molecular mechanism of the LIM protein Ajuba and the transcription factor SP1 in the pathogenesis and progression of PDAC. Ajuba is a newly defined transcriptional co-re...

    Authors: Bosen Zhang, Liwei Song, Jiali Cai, Lei Li, Hong Xu, Mengying Li, Jiamin Wang, Minmin Shi, Hao Chen, Hao Jia and Zhaoyuan Hou

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:205

    Published on:

  16. Content type: Research

    The treatment for advanced primary hepatocellular carcinoma (HCC) is sorafenib (SORA), while HCC has become increasingly drug resistant with enhanced aerobic glycolysis. The present study aimed to examine the ...

    Authors: Jiao Feng, Liwei Wu, Jie Ji, Kan Chen, Qiang Yu, Jie Zhang, Jiaojiao Chen, Yuqing Mao, Fan Wang, Weiqi Dai, Ling Xu, Jianye Wu and Chuanyong Guo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:204

    Published on:

  17. Content type: Research

    The VRK1 chromatin kinase regulates the organization of locally altered chromatin induced by DNA damage. The combination of ionizing radiation with inhibitors of DNA damage responses increases the accumulation...

    Authors: Ignacio Campillo-Marcos and Pedro A. Lazo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:203

    Published on:

  18. Content type: Research

    Glioblastoma multiforme (GBM), due to its location, aggressiveness, heterogeneity and infiltrative growth, is characterized by an exceptionally dismal clinical outcome. The small molecule SI113, recently ident...

    Authors: Silvia Matteoni, Claudia Abbruzzese, Paola Matarrese, Gabriele De Luca, Anna M. Mileo, Stefania Miccadei, Silvia Schenone, Francesca Musumeci, Tobias L. Haas, Giovanni Sette, Carmine M. Carapella, Rosario Amato, Nicola Perrotti, Michele Signore and Marco G. Paggi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:202

    Published on:

  19. Content type: Research

    Cancer stem cells (CSCs), which are involved in cancer initiation and metastasis, could potentially release exosomes that mediate cellular communication by delivering microRNAs (miRNAs). Based on the role of m...

    Authors: Zhi-Fei Wang, Fan Liao, Hao Wu and Jin Dai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:201

    Published on:

  20. Content type: Research

    Acute myeloid leukemia (AML) is initiated and maintained by a unique, small subset of leukemia stem cells (LSCs). LSCs are characterized by unrestricted self-renewal and contribute to the malignancy of leukemi...

    Authors: Bing Liu, Hongye Ma, Qianqian Liu, Yang Xiao, Shimeng Pan, Huimin Zhou and Li Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:200

    Published on:

  21. Content type: Research

    Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal ...

    Authors: Qianqian Liu, Hongye Ma, Xiuhua Sun, Bing Liu, Yang Xiao, Shimeng Pan, Huimin Zhou, Weijie Dong and Li Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:199

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:357

  22. Content type: Review

    Hepatocellular carcinoma (HCC) is one of the most notable lethal malignancies worldwide. However, the molecular mechanisms involved in the initiation and progression of this disease remain poorly understood. O...

    Authors: Haoming Mai, Bin Zhou, Li Liu, Fu Yang, Carly Conran, Yuan Ji, Jinlin Hou and Deke Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:198

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:352

  23. Content type: Research

    Cancer pain is a debilitating disorder of human breast cancer and a primary determinant of the poor quality of life, and relieving pain is fundamental strategy in the cancer treatment. However, opioid analgesi...

    Authors: Jiachuan Yu, Yuanyuan Luo and Qingping Wen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:197

    Published on:

  24. Content type: Research

    Deregulation of protein translation control is a hallmark of cancers. Eukaryotic initiation factor 4A2 (EIF4A2) is required for mRNA binding to ribosome and plays an important role in translation initiation. H...

    Authors: Zhan-Hong Chen, Jing-Jing Qi, Qi-Nian Wu, Jia-Huan Lu, Ze-Xian Liu, Yun Wang, Pei-Shan Hu, Ting Li, Jin-Fei Lin, Xiang-Yuan Wu, Lei Miao, Zhao-Lei Zeng, Dan Xie, Huai-Qiang Ju, Rui-Hua Xu and Feng Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:196

    Published on:

  25. Content type: Review

    Triple negative breast cancer (TNBC), which is typically lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), represents the most aggre...

    Authors: Jiang-Jiang Qin, Li Yan, Jia Zhang and Wei-Dong Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:195

    Published on:

  26. Content type: Research

    Accumulating evidence has highlighted the potential role of long non-coding RNAs (lncRNAs) in the biological behaviors of hepatocellular carcinoma (HCC). Here, we elucidated the function and possible molecular...

    Authors: Zhikui Liu, Yufeng Wang, Liang Wang, Bowen Yao, Liankang Sun, Runkun Liu, Tianxiang Chen, Yongshen Niu, Kangsheng Tu and Qingguang Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:194

    Published on:

  27. Content type: Research

    Several targeted immunotherapies have recently showed significant advances in treatment of non-small cell lung cancer (NSCLC), including antibodies and inhibitors targeting programmed death-1 (PD-1) and its li...

    Authors: Yanhui Chen, Quanxing Liu, Zhiming Chen, Yating Wang, Wanning Yang, Ying Hu, Wenbo Han, Hui Zeng, Haitao Ma, Jigang Dai and Henghui Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:193

    Published on:

  28. Content type: Research

    Modulation of cell surface expression of MHC class I chain-related protein A/B (MICA/B) has been proven to be one of the mechanisms by which tumor cells escape from NK cell-mediated killing. Abnormal metabolic...

    Authors: Qingke Duan, Hehe Li, Chenggang Gao, Hengqiang Zhao, Shihong Wu, Heshui Wu, Chunyou Wang, Qiang Shen and Tao Yin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:192

    Published on:

  29. Content type: Research

    The very aggressive nature and low survival rate of pancreatic ductal adenocarcinoma (PDAC) dictates the necessity to find novel efficacious therapies. Recent evidence suggests that phosphoinositide 3-kinase (...

    Authors: Aikaterini Emmanouilidi, Chanse A. Fyffe, Riccardo Ferro, Charlotte E. Edling, Emily Capone, Simona Sestito, Simona Rapposelli, Rossano Lattanzio, Stefano Iacobelli, Gianluca Sala, Tania Maffucci and Marco Falasca

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:191

    Published on:

  30. Content type: Research

    One of the most potent costimulatory molecules involved in the recognition and killing of tumor cells is CD80. However, its role and the molecular mechanisms regulating its expression in sporadic colorectal ca...

    Authors: Chiara Marchiori, Melania Scarpa, Andromachi Kotsafti, Susan Morgan, Matteo Fassan, Vincenza Guzzardo, Andrea Porzionato, Imerio Angriman, Cesare Ruffolo, Stefania Sut, Stefano Dall’Acqua, Romeo Bardini, Raffaele De Caro, Carlo Castoro, Marco Scarpa and Ignazio Castagliuolo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:190

    Published on:

  31. Content type: Research

    Hepatocellular carcinoma (HCC) is still the most common cause of tumor-related death worldwide and accumulating studies report that long non-coding RNAs (LncRNAs) are closely related with HCC development, meta...

    Authors: Hongda Ding, Junpeng Liu, Ruoyao Zou, Pengrui Cheng and Yang Su

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:189

    Published on:

  32. Content type: Research

    Forkhead box M1 (FOXM1) is a proliferation-associated transcription factor of the forkhead box proteins superfamily, which includes four isoforms FOXM1a, b, c, and d. FOXM1 has been implicated in hepatocellula...

    Authors: Guohui Hu, Zhengwei Yan, Cheng Zhang, Minzhang Cheng, Yehong Yan, Yiting Wang, Libin Deng, Quqin Lu and Shiwen Luo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:188

    Published on:

  33. Content type: Research

    Current prognostic tools and targeted therapeutic approaches have limited value for metastatic triple negative breast cancer (TNBC). Building upon current knowledge, we hypothesized that epoxyeicosatrienoic ac...

    Authors: Maria Karmella Apaya, Jeng-Yuan Shiau, Guo-Shiou Liao, Yu-Jen Liang, Chia-Wei Chen, Hsin-Chou Yang, Chi-Hong Chu, Jyh-Cherng Yu and Lie-Fen Shyur

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:187

    Published on:

  34. Content type: Research

    Breast cancer is the most prevalent cancer among women. In triple-negative breast cancer (TNBC) cells, a novel quinone derivative, coenzyme Q0 (CoQ0), promotes apoptosis and cell-cycle arrest. This study explored...

    Authors: Hsin-Ling Yang, Varadharajan Thiyagarajan, Pei-Chun Shen, Dony Chacko Mathew, Kai-Yuan Lin, Jiunn-Wang Liao and You-Cheng Hseu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:186

    Published on:

  35. Content type: Research

    Malignant peripheral nerve sheath tumours (MPNSTs) are sarcomas of Schwann cell lineage origin that occur sporadically or in association with the inherited syndrome, neurofibromatosis type 1 (NF1). This study ...

    Authors: Kang Yang, Wei Guo, Tingting Ren, Yi Huang, Yu Han, Hongliang Zhang and Jie Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:185

    Published on:

  36. Content type: Research

    Celastrol, a triterpene compound derived from the traditional Chinese medicine Tripterygium wilfordii, has been reported to possess potential antitumor activity towards various malignancies. However, the effect o...

    Authors: Xihong Liu, Peiyuan Zhao, Xiujuan Wang, Lei Wang, Yingjun Zhu, Yadi Song and Wei Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:184

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:284

  37. Content type: Research

    Acquired resistance to sorafenib greatly limits its therapeutic efficiency in the treatment of hepatocellular carcinoma (HCC). Increasing evidence indicates that long noncoding RNAs (lncRNAs) play important ro...

    Authors: Weidong Li, Xuesong Dong, Changjun He, Gang Tan, Ziyi Li, Bo Zhai, Jing Feng, Xian Jiang, Chang Liu, Hongchi Jiang and Xueying Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:183

    Published on:

  38. Content type: Research

    MicroRNA-139-5p (miR-139) has been shown to play important roles in hepatocellular carcinoma (HCC) development. However, the exact mechanism of miR-139 in HCC remains largely unknown.

    Authors: Ying Zan, Baofeng Wang, Liang Liang, Yujiao Deng, Tian Tian, Zhijun Dai and Lei Dong

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:182

    Published on:

  39. Content type: Research

    GMEB1 was originally identified via its interaction with GMEB2, which binds to the promoter region of the tyrosine aminotransferase (TAT) gene and modulates transactivation of the glucocorticoid receptor gene. In...

    Authors: Wentao An, Shun Yao, Xiaoyang Sun, Zhaoyuan Hou, Yidan Lin, Ling Su and Xiangguo Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:181

    Published on:

  40. Content type: Research

    Lung cancer often ranks one of the most prevalent malignancies in the world. One of the most challenging aspects of treating late-stage lung cancer patients is the development of drug resistance, from both con...

    Authors: Wen-Chien Huang, Kuang-Tai Kuo, Chun-Hua Wang, Chi-Tai Yeh and Yongjie Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:180

    Published on:

  41. Content type: Research

    Recent studies have revealed that numerous oncogenic long non-coding RNAs (lncRNAs) play pivotal roles in pancreatic ductal adenocarcinoma (PDAC) progression, but little is known about tumor-suppressive lncRNA...

    Authors: Jing Ling, Fan Wang, Chuan Liu, Xiao Dong, Ying Xue, Xuebing Jia, Weifeng Song and Qi Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:179

    Published on:

  42. Content type: Research

    Pioglitazone, a synthetic peroxisome proliferator activated receptor (PPAR-γ) ligand, is known as an antidiabetic drug included in the thiazolidinediones (TZDs) class. It regulates the lipid and glucose cell m...

    Authors: Vincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello, Carminia Maria Della Corte, Giusi Barra, Giuseppe Viscardi, Giovanna Esposito, Francesca Sparano, Teresa Troiani, Erika Martinelli, Michele Orditura, Ferdinando De Vita, Fortunato Ciardiello and Floriana Morgillo

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:178

    Published on:

  43. Content type: Correction

    .

    Authors: Sen Li, Xiliang Cong, Hongyu Gao, Xiuwen Lan, Zhiguo Li, Wenpeng Wang, Shubin Song, Yimin Wang, Chunfeng Li, Hongfeng Zhang, Yuzhou Zhao and Yingwei Xue

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:177

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:6

  44. Content type: Research

    High-grade serous ovarian cancer (HGSOC) is the most lethal of all gynecological malignancies. Patients often suffer from chemoresistance. Several studies have reported that Fn14 could regulate migration, inva...

    Authors: An-Yue Wu, Li-Ying Gu, Wei Cang, Meng-Xing Cheng, Wen-Jing Wang, Wen Di, Lei Huang and Li-Hua Qiu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:176

    Published on:

  45. Content type: Research

    Head and neck squamous-cell carcinoma (HNSCC) ranks sixth among cancers worldwide. Though several molecular mechanisms of tumor initiation and progression of HNSCC are known, others remain unclear. Significanc...

    Authors: Sourabh Soni, Munish Kumar Saroch, Bal Chander, Narendra Vijay Tirpude and Yogendra S. Padwad

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:175

    Published on:

  46. Content type: Research

    Non-small cell lung cancer (NSCLC) is a devastating disease with a heterogeneous prognosis, and the molecular mechanisms underlying tumor progression remain elusive. Mammalian Eps15 homology domain 1 (EHD1) pl...

    Authors: Ting Wang, Ying Xing, Qingwei Meng, Hailing Lu, Wei Liu, Shi Yan, Yang Song, Xinyuan Xu, Jian Huang, Yue Cui, Dexin Jia and Li Cai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:174

    Published on:

  47. Content type: Research

    Breast cancer angiogenesis is key for metastasis and predicts a poor prognosis. Angiotensin-converting enzyme 2 (ACE2), as a member of the renin-angiotensin system (RAS), was reported to restrain the progressi...

    Authors: Qi Zhang, Sihong Lu, Tianfu Li, Liang Yu, Yunjian Zhang, Huijuan Zeng, Xueke Qian, Jiong Bi and Ying Lin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:173

    Published on:

  48. Content type: Research

    Thousands of long noncoding RNAs (lncRNAs) are aberrantly expressed in various types of cancers, however our understanding of their role in the disease is still very limited.

    Authors: Morvarid Saeinasab, Ahmad Reza Bahrami, Jovanna González, Francesco P. Marchese, Dannys Martinez, Seyed Javad Mowla, Maryam M. Matin and Maite Huarte

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:172

    Published on:

  49. Content type: Review

    Cancer-associated fibroblasts (CAFs) plays an essential role in cancer cell growth, metabolism and immunoreaction. Autophagy is an intracellular self-degradative process that balances cell energy source and re...

    Authors: Yuanliang Yan, Xi Chen, Xiang Wang, Zijin Zhao, Wenfeng Hu, Shuangshuang Zeng, Jie Wei, Xue Yang, Long Qian, Shuyi Zhou, Lunquan Sun, Zhicheng Gong and Zhijie Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:171

    Published on:

  50. Content type: Research

    FGFR3 plays an important role in the development of bladder cancer (BCa). Hsa_circ_0068871 is a circRNA generated from several exons of FGFR3. However, the potential functional role of hsa_circ_0068871 in BCa ...

    Authors: Weipu Mao, Xin Huang, Longsheng Wang, Ziwei Zhang, Mengnan Liu, Yan Li, Ming Luo, Xudong Yao, Jie Fan and Jiang Geng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:169

    Published on:

Annual Journal Metrics

Advertisement